Citadel Advisors LLC 13D and 13G filings for Immuneering Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:15 pm Sale |
2024-09-30 | 13G | Immuneering Corporation IMRX |
Citadel Advisors LLC | 2,672 0.000% |
-2,075,420 (-99.87%) |
Filing |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Immuneering Corporation IMRX |
Citadel Advisors LLC | 2,078,092 7.100% |
-63,405 (-2.96%) |
Filing |
| 2023-02-14 08:14 am Purchase |
2022-12-31 | 13G | Immuneering Corporation IMRX |
Citadel Advisors LLC | 2,141,497 8.100% |
83,349 (+4.05%) |
Filing |
| 2022-02-14 06:22 am Sale |
2021-12-31 | 13G | Immuneering Corporation IMRX |
Citadel Advisors LLC | 2,058,148 7.800% |
-4,528 (-0.22%) |
Filing |
| 2021-08-13 4:02 pm Purchase |
2021-08-03 | 13G | Immuneering Corporation IMRX |
Citadel Advisors LLC | 2,062,676 8.000% |
2,062,676 (New Position) |
Filing |